Edition:
United States

Aileron Therapeutics Inc (ALRN.OQ)

ALRN.OQ on NASDAQ Stock Exchange Global Market

4.85USD
4:00pm EDT
Change (% chg)

$-0.17 (-3.39%)
Prev Close
$5.02
Open
$5.00
Day's High
$5.14
Day's Low
$4.85
Volume
11,964
Avg. Vol
14,760
52-wk High
$15.34
52-wk Low
$4.85

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.00 -0.515
FY 2017 Dec '17 0.00 -0.466
Sep '17 0.00 -0.425
Jun '17 0.00 -0.336
Mar '17 0.00 -0.311
FY 2016 Dec '16 0.00 -0.303
Sep '16 0.00 -0.288
Jun '16 0.00 -0.377
Mar '16 0.00 -0.268
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 4 0.00 0.00 0.00 --
Quarter Ending Dec-18 4 0.00 0.00 0.00 --
Year Ending Dec-18 4 0.00 0.00 0.00 --
Year Ending Dec-19 4 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Sep-18 4 -0.56 -0.49 -0.62 --
Quarter Ending Dec-18 4 -0.57 -0.46 -0.67 --
Year Ending Dec-18 4 -2.18 -1.95 -2.38 --
Year Ending Dec-19 4 -2.67 -2.11 -3.92 --
LT Growth Rate (%) 1 1.20 1.20 1.20 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 214.97 33.20
P/E High - Last 5 Yrs. -- 284.72 47.16
P/E Low - Last 5 Yrs. -- 97.29 25.03
Beta -- 0.77 0.82
Price to Sales (TTM) -- 251.09 8.07
Price to Book (MRQ) 1.81 21.04 4.28
Price to Tangible Book (MRQ) 1.81 27.67 6.02
Price to Cash Flow (TTM) -- 128.42 22.38
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.36 1.72
Dividend Yield - 5 Year Avg -- 0.21 1.46
Dividend 5 Year Growth Rate -- 2.26 -6.51
Payout Ratio(TTM) -- 81.48 47.13

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 33.21 6.45
Sales (TTM) vs TTM 1 Yr. Ago -- 147.67 12.44
Sales - 5 Yr. Growth Rate -- 30.72 7.73
EPS (MRQ) vs Qtr. 1 Yr. Ago -65.54 -74.82 45.89
EPS (TTM) vs TTM 1 Yr. Ago -36.12 -- --
EPS - 5 Yr. Growth Rate -- 47.09 7.99
Capital Spending - 5 Yr. Growth Rate -- 42.70 7.69

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.72 2.57
Current Ratio (MRQ) 9.15 6.59 3.65
LT Debt to Equity (MRQ) 0.00 23.42 13.21
Total Debt to Equity (MRQ) 0.00 27.63 17.39
Interest Coverage (TTM) -- -148.17 35.20

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.05 55.10
Gross Margin - 5 Yr. Avg. -- 53.56 53.12
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -181.19 15.68
Operating Margin (TTM) -- -954.02 -0.51
Operating Margin - 5 Yr. Avg. -- -194.86 10.86
Pre-Tax Margin (TTM) -- -849.49 1.29
Pre-Tax Margin - 5 Yr. Avg. -- -199.42 11.00
Net Profit Margin (TTM) -- -840.78 -2.00
Net Profit Margin - 5 Yr. Avg. -- -197.22 7.35
Effective Tax Rate (TTM) -- 14.88 20.80
Effective Tax Rate - 5 Yr. Avg. -- 19.11 24.26

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 23,460,657 746,903,749
Net Income/Employee (TTM) -- -801,365 87,147,894
Receivable Turnover (TTM) -- 17.81 5.99
Inventory Turnover (TTM) -- 2.84 3.70
Asset Turnover (TTM) 0.00 0.48 0.88

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -81.40 3.19 10.49
Return on Assets - 5 Yr. Avg. -- 2.93 11.10
Return on Investment (TTM) -92.78 -3.79 13.23
Return on Investment - 5 Yr. Avg. -- 2.73 14.34
Return on Equity (TTM) -- -5.32 15.28
Return on Equity - 5 Yr. Avg. -- -3.26 15.70
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -24.32 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aileron Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 28.66%
# of Holders: 48
Total Shares Held: 4,223,495
3 Mo. Net Change: -253,477
# New Positions: 0
# Closed Positions: 1
# Increased Positions: 2
# Reduced Positions: 3
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.